SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Alisha M. Mavis, Estella M. Alonso, Liver Disease in the Adolescent, Clinics in Liver Disease, 2015, 19, 1, 171

    CrossRef

  2. 2
    Akira Sasaki, Hiroyuki Nitta, Koki Otsuka, Akira Umemura, Shigeaki Baba, Toru Obuchi, Go Wakabayashi, Bariatric Surgery and Non-Alcoholic Fatty Liver Disease: Current and Potential Future Treatments, Frontiers in Endocrinology, 2014, 5,

    CrossRef

  3. 3
    Abigale Lade, Luke A. Noon, Scott L. Friedman, Contributions of metabolic dysregulation and inflammation to nonalcoholic steatohepatitis, hepatic fibrosis, and cancer, Current Opinion in Oncology, 2014, 26, 1, 100

    CrossRef

  4. 4
    Anna Stears, Catherine Hames, Diagnosis and management of lipodystrophy: a practical update, Clinical Lipidology, 2014, 9, 2, 235

    CrossRef

  5. 5
    Niraj S. Patel, Iliana Doycheva, Michael R. Peterson, Jonathan Hooker, Tatiana Kisselva, Bernd Schnabl, Ekihiro Seki, Claude B. Sirlin, Rohit Loomba, Effect of Weight Loss on Magnetic Resonance Imaging Estimation of Liver Fat and Volume in Patients With Nonalcoholic Steatohepatitis, Clinical Gastroenterology and Hepatology, 2014,

    CrossRef

  6. 6
    Swastik Agrawal, Radha K. Dhiman, Hepatobiliary Quiz—10 (2014), Journal of Clinical and Experimental Hepatology, 2014, 4, 2, 184

    CrossRef

  7. 7
    Llorenç Caballería, Joan Saló, Annalisa Berzigotti, Ramón Planas, Carme Vila, Carlos Huertas, Miquel Torres, Pere Torán, Joan Caballería, Hígado graso no alcohólico. Documento de posicionamiento de la Societat Catalana de Digestologia, Gastroenterología y Hepatología, 2014, 37, 6, 372

    CrossRef

  8. 8
    Mariana Verdelho Machado, Helena Cortez-Pinto, Management of fatty liver disease with the metabolic syndrome, Expert Review of Gastroenterology & Hepatology, 2014, 8, 5, 487

    CrossRef

  9. 9
    J. K. Dyson, Q. M. Anstee, S. McPherson, Non-alcoholic fatty liver disease: a practical approach to treatment, Frontline Gastroenterology, 2014, 5, 4, 277

    CrossRef

  10. 10
    M. Pallayova, S. Taheri, Non-alcoholic fatty liver disease in obese adults: clinical aspects and current management strategies, Clinical Obesity, 2014, 4, 5
  11. 11
    AiXuan Holterman, Juan Gurria, Smita Tanpure, Nerina DiSomma, Nonalcoholic fatty liver disease and bariatric surgery in adolescents, Seminars in Pediatric Surgery, 2014, 23, 1, 49

    CrossRef

  12. 12
    Ki Deok Yoo, Dae Won Jun, Nonalcoholic Fatty Liver Disease: Lifestyle Modification, Korean Journal of Medicine, 2014, 86, 4, 416

    CrossRef

  13. 13
    Sean W.P. Koppe, Obesity and the liver: nonalcoholic fatty liver disease, Translational Research, 2014, 164, 4, 312

    CrossRef

  14. 14
    D. Sall, J. Wang, M. Rashkin, M. Welch, C. Droege, D. Schauer, Orlistat-induced fulminant hepatic failure, Clinical Obesity, 2014, 4, 6
  15. 15
    Minjie Lin, Shuiping Zhao, Li Shen, Danyan Xu, Potential Approaches to Ameliorate Hepatic Fat Accumulation Seen with MTP Inhibition, Drug Safety, 2014, 37, 4, 213

    CrossRef

  16. 16
    E. B. Mitchel, J. E. Lavine, Review article: the management of paediatric nonalcoholic fatty liver disease, Alimentary Pharmacology & Therapeutics, 2014, 40, 10
  17. 17
    Richele L. Corrado, Dawn M. Torres, Stephen A. Harrison, Review of Treatment Options for Nonalcoholic Fatty Liver Disease, Medical Clinics of North America, 2014, 98, 1, 55

    CrossRef

  18. 18
    Paola Portillo, Sahzene Yavuz, Fernando Bril, Kenneth Cusi, Role of Insulin Resistance and Diabetes in the Pathogenesis and Treatment of Nonalcoholic Fatty Liver Disease, Current Hepatology Reports, 2014, 13, 2, 159

    CrossRef

  19. 19
    M. J. Armstrong, J. M. Hazlehurst, R. Parker, E. Koushiappi, J. Mann, S. Khan, A. Philips, L. Chandler, J. Johnson, M. Round, G. Haydon, M. A. Karamat, P. N. Newsome, J. W. Tomlinson, Severe asymptomatic non-alcoholic fatty liver disease in routine diabetes care; a multi-disciplinary team approach to diagnosis and management, QJM, 2014, 107, 1, 33

    CrossRef

  20. 20
    Michelle Pearlman, Rohit Loomba, State of the art, Current Opinion in Gastroenterology, 2014, 30, 3, 223

    CrossRef

  21. You have free access to this content21
    Z. M. Younossi, M. J. Reyes, A. Mishra, R. Mehta, L. Henry, Systematic review with meta-analysis: non-alcoholic steatohepatitis - a case for personalised treatment based on pathogenic targets, Alimentary Pharmacology & Therapeutics, 2014, 39, 1
  22. 22
    Francisco Barrera, Jacob George, The Role of Diet and Nutritional Intervention for the Management of Patients with NAFLD, Clinics in Liver Disease, 2014, 18, 1, 91

    CrossRef

  23. 23
    Natalia Mazzella, Laura M. Ricciardi, Arianna Mazzotti, Giulio Marchesini, The Role of Medications for the Management of Patients with NAFLD, Clinics in Liver Disease, 2014, 18, 1, 73

    CrossRef

  24. 24
    Lisa M. Glass, Rolland C. Dickson, Joseph C. Anderson, Arief A. Suriawinata, Juan Putra, Brian S. Berk, Arifa Toor, Total Body Weight Loss of ≥10 % Is Associated with Improved Hepatic Fibrosis in Patients with Nonalcoholic Steatohepatitis, Digestive Diseases and Sciences, 2014,

    CrossRef

  25. 25
    Shira Zelber-Sagi, Liver Metabolism and Fatty Liver Disease, 2014,

    CrossRef

  26. 26
    Olga Melzer, Michael Rothkopf, Lisa Ganjhu, Metabolic Medicine and Surgery, 2014,

    CrossRef

  27. 27
    Bashar M. Attar, David H. Van Thiel, Current Concepts and Management Approaches in Nonalcoholic Fatty Liver Disease, The Scientific World Journal, 2013, 2013, 1

    CrossRef

  28. 28
    Xin Gao, Jian-Gao Fan, Diagnosis and management of non-alcoholic fatty liver disease and related metabolic disorders: Consensus statement from the Study Group of Liver and Metabolism, Chinese Society of Endocrinology (非酒精性脂肪性肝病与相关代谢紊乱诊疗共识——中华医学会内分泌学分会肝病与代谢学组), Journal of Diabetes, 2013, 5, 4
  29. 29
    Emily R. Perito, Luis A. Rodriguez, Robert H. Lustig, Dietary treatment of nonalcoholic steatohepatitis, Current Opinion in Gastroenterology, 2013, 29, 2, 170

    CrossRef

  30. 30
    Marietta Charakida, Dimitris Tousoulis, Nicholas Finer, Drug treatment of obesity in the cardiovascular patient, Current Opinion in Cardiology, 2013, 28, 5, 584

    CrossRef

  31. 31
    KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease, Clinical and Molecular Hepatology, 2013, 19, 4, 325

    CrossRef

  32. 32
    Manage non-alcoholic fatty liver disease using lifestyle interventions, as evidence for the use of pharmacological options is limited, Drugs & Therapy Perspectives, 2013, 29, 8, 228

    CrossRef

  33. 33
    Alexandra K. Leamy, Robert A. Egnatchik, Jamey D. Young, Molecular mechanisms and the role of saturated fatty acids in the progression of non-alcoholic fatty liver disease, Progress in Lipid Research, 2013, 52, 1, 165

    CrossRef

  34. 34
    A. N. Mavrogiannaki, I. N. Migdalis, Nonalcoholic Fatty Liver Disease, Diabetes Mellitus and Cardiovascular Disease: Newer Data, International Journal of Endocrinology, 2013, 2013, 1

    CrossRef

  35. 35
    Howard C. Masuoka, Naga Chalasani, Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals, Annals of the New York Academy of Sciences, 2013, 1281, 1
  36. 36
    Romina Lomonaco, Nishanth E. Sunny, Fernando Bril, Kenneth Cusi, Nonalcoholic Fatty Liver Disease: Current Issues and Novel Treatment Approaches, Drugs, 2013, 73, 1, 1

    CrossRef

  37. 37
    Barbara Fruci, Stefania Giuliano, Angela Mazza, Roberta Malaguarnera, Antonino Belfiore, Nonalcoholic Fatty Liver: A Possible New Target for Type 2 Diabetes Prevention and Treatment, International Journal of Molecular Sciences, 2013, 14, 11, 22933

    CrossRef

  38. 38
    Ryan M. Gill, Sanjay Kakar, Nonalcoholic Steatohepatitis, Surgical Pathology Clinics, 2013, 6, 2, 227

    CrossRef

  39. 39
    Scott S. Malinowski, Jennifer S. Byrd, Allison M. Bell, Marion R. Wofford, Daniel M. Riche, Pharmacologic Therapy for Nonalcoholic Fatty Liver Disease in Adults, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2013, 33, 2
  40. 40
    Maeva Guillaume, Vlad Ratziu, Pharmacological agents for nonalcoholic steatohepatitis, Hepatology International, 2013, 7, S2, 833

    CrossRef

  41. 41
    J. F. L. Cobbold, S. Raveendran, C. M. Peake, Q. M. Anstee, M. S. Yee, M. R. Thursz, Piloting a multidisciplinary clinic for the management of non-alcoholic fatty liver disease: initial 5-year experience, Frontline Gastroenterology, 2013, 4, 4, 263

    CrossRef

  42. 42
    Antonio Iannelli, Francesco Martini, Anne Sophie Schneck, Bijan Ghavami, Guillaume Baudin, Rodolphe Anty, Jean Gugenheim, Preoperative 4-Week Supplementation with Omega-3 Polyunsaturated Fatty Acids Reduces Liver Volume and Facilitates Bariatric Surgery in Morbidly Obese Patients, Obesity Surgery, 2013, 23, 11, 1761

    CrossRef

  43. You have free access to this content43
    Angelo H. Paredes, Dawn M. Torres, Stephen A. Harrison, Tratamiento de la enfermedad por hígado graso no alcohólico: Papel de las modificaciones dietéticas y el ejercicio, Clinical Liver Disease, 2013, 2, S4
  44. 44
    Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Anthony Wing-Hung Chan, Winnie Chiu-Wing Chu, Paul Cheung-Lung Choi, Angel Mei-Ling Chim, Karen Kar-Lum Yiu, Jun Yu, Francis Ka-Leung Chan, Henry Lik-Yuen Chan, Treatment of non-alcoholic steatohepatitis with Phyllanthus urinaria: A randomized trial, Journal of Gastroenterology and Hepatology, 2013, 28, 1
  45. 45
    Marc Morris, Peter Lane, Kwan Lee, Daniel Parks, An Integrated Analysis of Liver Safety Data from Orlistat Clinical Trials, Obesity Facts, 2012, 5, 4, 485

    CrossRef

  46. 46
    Elizabeth L. Ellis, Derek A. Mann, Clinical evidence for the regression of liver fibrosis, Journal of Hepatology, 2012, 56, 5, 1171

    CrossRef

  47. 47
    Brent A. Neuschwander-Tetri, David A. Ford, Sahaja Acharya, George Gilkey, Metin Basaranoglu, Laura H. Tetri, Elizabeth M. Brunt, Dietary trans-Fatty Acid Induced NASH is Normalized Following Loss of trans-Fatty Acids from Hepatic Lipid Pools, Lipids, 2012, 47, 10, 941

    CrossRef

  48. 48
    Dawn M. Torres, Christopher D. Williams, Stephen A. Harrison, Features, Diagnosis, and Treatment of Nonalcoholic Fatty Liver Disease, Clinical Gastroenterology and Hepatology, 2012, 10, 8, 837

    CrossRef

  49. 49
    Swastik Agrawal, Radha K.. Dhiman, Hepatobiliary Quiz-3 (2012), Journal of Clinical and Experimental Hepatology, 2012, 2, 3, 297

    CrossRef

  50. 50
    G. Musso, M. Cassader, F. Rosina, R. Gambino, Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials, Diabetologia, 2012, 55, 4, 885

    CrossRef

  51. 51
    Mattias Ekstedt, Lennart E. Franzén, Ulrik L. Mathiesen, Stergios Kechagias, Low clinical relevance of the nonalcoholic fatty liver disease activity score (NAS) in predicting fibrosis progression, Scandinavian Journal of Gastroenterology, 2012, 47, 1, 108

    CrossRef

  52. 52
    Thuy-Anh Le, Rohit Loomba, Management of Non-alcoholic Fatty Liver Disease and Steatohepatitis, Journal of Clinical and Experimental Hepatology, 2012, 2, 2, 156

    CrossRef

  53. 53
    Suzanne E. Mahady, Jacob George, Management of Nonalcoholic Steatohepatitis, Clinics in Liver Disease, 2012, 16, 3, 631

    CrossRef

  54. You have free access to this content54
    Vlad Ratziu, Management of nonalcoholic steatohepatitis: Pharmacotherapy, Clinical Liver Disease, 2012, 1, 4
  55. 55
    Kei Nakajima, Multidisciplinary Pharmacotherapeutic Options for Nonalcoholic Fatty Liver Disease, International Journal of Hepatology, 2012, 2012, 1

    CrossRef

  56. 56
    Ana C. TUYAMA, Charissa Y. CHANG, Non-alcoholic fatty liver disease, Journal of Diabetes, 2012, 4, 3
  57. 57
    Angelo H. Paredes, Dawn M. Torres, Stephen A. Harrison, Nonalcoholic Fatty Liver Disease, Clinics in Liver Disease, 2012, 16, 2, 397

    CrossRef

  58. 58
    Sindu Stephen, Ancha Baranova, Zobair M Younossi, Nonalcoholic fatty liver disease and bariatric surgery, Expert Review of Gastroenterology & Hepatology, 2012, 6, 2, 163

    CrossRef

  59. 59
    Helen M. Parker, Nathan A. Johnson, Catriona A. Burdon, Jeffrey S. Cohn, Helen T. O’Connor, Jacob George, Omega-3 supplementation and non-alcoholic fatty liver disease: A systematic review and meta-analysis, Journal of Hepatology, 2012, 56, 4, 944

    CrossRef

  60. 60
    Benjamin Rodriguez, Dawn M. Torres, Stephen A. Harrison, Physical activity: an essential component of lifestyle modification in NAFLD, Nature Reviews Gastroenterology & Hepatology, 2012, 9, 12, 726

    CrossRef

  61. 61
    Shira Zelber-Sagi, Roni Lotan, Amir Shlomai, Muriel Webb, Gil Harrari, Assaf Buch, Dorit Nitzan Kaluski, Zamir Halpern, Ran Oren, Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up, Journal of Hepatology, 2012, 56, 5, 1145

    CrossRef

  62. 62
    Karen E. Stewart, James L. Levenson, Psychological and Psychiatric Aspects of Treatment of Obesity and Nonalcoholic Fatty Liver Disease, Clinics in Liver Disease, 2012, 16, 3, 615

    CrossRef

  63. 63
    Kenneth Cusi, Role of Obesity and Lipotoxicity in the Development of Nonalcoholic Steatohepatitis: Pathophysiology and Clinical Implications, Gastroenterology, 2012, 142, 4, 711

    CrossRef

  64. 64
    Naga Chalasani, Zobair Younossi, Joel E Lavine, Anna Mae Diehl, Elizabeth M Brunt, Kenneth Cusi, Michael Charlton, Arun J Sanyal, The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association, The American Journal of Gastroenterology, 2012, 107, 6, 811

    CrossRef

  65. 65
    Naga Chalasani, Zobair Younossi, Joel E. Lavine, Anna Mae Diehl, Elizabeth M. Brunt, Kenneth Cusi, Michael Charlton, Arun J. Sanyal, The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology, Gastroenterology, 2012, 142, 7, 1592

    CrossRef

  66. You have free access to this content66
    Naga Chalasani, Zobair Younossi, Joel E. Lavine, Anna Mae Diehl, Elizabeth M. Brunt, Kenneth Cusi, Michael Charlton, Arun J. Sanyal, The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association, Hepatology, 2012, 55, 6
  67. You have free access to this content67
    Angelo H. Paredes, Dawn M. Torres, Stephen A. Harrison, Treatment of nonalcoholic fatty liver disease: Role of dietary modification and exercise, Clinical Liver Disease, 2012, 1, 4
  68. 68
    F. Scaglioni, S. Ciccia, M. Marino, G. Bedogni, S. Bellentani, ASH and NASH, Digestive Diseases, 2011, 29, 2, 202

    CrossRef

  69. 69
    J. K. Dowman, M. J. Armstrong, J. W. Tomlinson, P. N. Newsome, Current therapeutic strategies in non-alcoholic fatty liver disease, Diabetes, Obesity and Metabolism, 2011, 13, 8
  70. 70
    Ravi Juluri, Raj Vuppalanchi, John Olson, Aynur Ünalp, Mark L. Van Natta, Oscar W. Cummings, James Tonascia, Naga Chalasani, Generalizability of the Nonalcoholic Steatohepatitis Clinical Research Network Histologic Scoring System for Nonalcoholic Fatty Liver Disease, Journal of Clinical Gastroenterology, 2011, 45, 1, 55

    CrossRef

  71. 71
    Amedeo Lonardo, Stefano Bellentani, Vlad Ratziu, Paola Loria, Insulin resistance in nonalcoholic steatohepatitis: necessary but not sufficient – death of a dogma from analysis of therapeutic studies?, Expert Review of Gastroenterology & Hepatology, 2011, 5, 2, 279

    CrossRef

  72. 72
    Simona Moscatiello, Raffaella Di Luzio, Anna Simona Sasdelli, Giulio Marchesini, Managing the combination of nonalcoholic fatty liver disease and metabolic syndrome, Expert Opinion on Pharmacotherapy, 2011, 12, 17, 2657

    CrossRef

  73. 73
    Briohny W. Smith, Leon A. Adams, Non-alcoholic fatty liver disease, Critical Reviews in Clinical Laboratory Sciences, 2011, 48, 3, 97

    CrossRef

  74. 74
    Briohny W. Smith, Leon A. Adams, Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment, Nature Reviews Endocrinology, 2011, 7, 8, 456

    CrossRef

  75. 75
    Sombat Treeprasertsuk, Francisco Lopez-Jimenez, Keith D. Lindor, Nonalcoholic Fatty Liver Disease and the Coronary Artery Disease, Digestive Diseases and Sciences, 2011, 56, 1, 35

    CrossRef

  76. 76
    Neil Parikh, Jawad Ahmad, Nonalcoholic Fatty Liver Disease: Pharmacologic and Surgical Options, Gastroenterology Clinics of North America, 2011, 40, 3, 541

    CrossRef

  77. 77
    Mariko Hojo, Sumio Watanabe, Pharmacological therapy of nonalcoholic steatohepatitis, Hepatology Research, 2011, 41, 3
  78. 78
    G. Osei-Assibey, Y. Adi, I. Kyrou, S. Kumar, K. Matyka, Pharmacotherapy for overweight/obesity in ethnic minorities and White Caucasians: a systematic review and meta-analysis, Diabetes, Obesity and Metabolism, 2011, 13, 5
  79. 79
    H. Castel, P. Mathurin, Stéatohépatite non alcoolique, EMC - Endocrinologie - Nutrition, 2011, 8, 3, 1

    CrossRef

  80. 80
    Mauro Maurantonio, Stefano Ballestri, Maria Rosaria Odoardi, Amedeo Lonardo, Paola Loria, Treatment of Atherogenic Liver Based on the Pathogenesis of Nonalcoholic Fatty Liver Disease: A Novel Approach to Reduce Cardiovascular Risk?, Archives of Medical Research, 2011, 42, 5, 337

    CrossRef

  81. 81
    Giulio Marchesini, Simona Moscatiello, Federica Agostini, Nicola Villanova, Davide Festi, Treatment of non-alcoholic fatty liver disease with focus on emerging drugs, Expert Opinion on Emerging Drugs, 2011, 16, 1, 121

    CrossRef

  82. 82
    Giovanni Musso, Roberto Gambino, Maurizio Cassader, Gianfranco Pagano, A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease, Hepatology, 2010, 52, 1
  83. 83
    Vlad Ratziu, Stefano Bellentani, Helena Cortez-Pinto, Chris Day, Giulio Marchesini, A position statement on NAFLD/NASH based on the EASL 2009 special conference, Journal of Hepatology, 2010, 53, 2, 372

    CrossRef

  84. 84
    Patrick R Kenny, Daniel E Brady, Dawn M Torres, Linda Ragozzino, Naga Chalasani, Stephen A Harrison, Exenatide in the Treatment of Diabetic Patients With Non-Alcoholic Steatohepatitis: A Case Series, The American Journal of Gastroenterology, 2010, 105, 12, 2707

    CrossRef

  85. 85
    Anna Mae Diehl, Hepatic Complications of Obesity, Gastroenterology Clinics of North America, 2010, 39, 1, 57

    CrossRef

  86. 86
    G. Musso, R. Gambino, M. Cassader, Non-alcoholic fatty liver disease from pathogenesis to management: an update, Obesity Reviews, 2010, 11, 6
  87. 87
    S. Kaser, C. F. Ebenbichler, H. Tilg, Pharmacological and non-pharmacological treatment of non-alcoholic fatty liver disease, International Journal of Clinical Practice, 2010, 64, 7
  88. 88
    G. S. MASTERTON, J. N. PLEVRIS, P. C. HAYES, Review article: omega-3 fatty acids - a promising novel therapy for non-alcoholic fatty liver disease, Alimentary Pharmacology & Therapeutics, 2010, 31, 7, 679

    CrossRef

  89. 89
    G. S. MASTERTON, J. N. PLEVRIS, P. C. HAYES, Review article: omega-3 fatty acids – a promising novel therapy for non-alcoholic fatty liver disease, Alimentary Pharmacology & Therapeutics, 2010, 31, 7
  90. 90
    Jeremy F. L. Cobbold, Quentin M. Anstee, Simon D. Taylor-Robinson, The importance of fatty liver disease in clinical practice, Proceedings of the Nutrition Society, 2010, 69, 04, 518

    CrossRef

  91. 91
    Stergios A. Polyzos, Jannis Kountouras, Christos Zavos, Eleni Tsiaousi, The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease, Diabetes, Obesity and Metabolism, 2010, 12, 5
  92. 92
    Stephen A. Harrison, Thiazolidinedione therapy for nonalcoholic steatohepatitis: Go, stop, or proceed with caution?, Hepatology, 2010, 51, 2
  93. 93
    Mathias Plauth, Tatjana Schütz, Nutritional Management of Digestive Disorders, 2010,

    CrossRef

  94. 94
    T. Pusl, C. Rust, K.G. Parhofer, Diabetes und Fettleber, Der Diabetologe, 2009, 5, 8, 653

    CrossRef

  95. 95
    TD Filippatos, CS Derdemezis, MS Elisaf, Effects of orlistat, alone or combined with hypolipidemic drugs, on cardiovascular risk factors, Clinical Lipidology, 2009, 4, 3, 331

    CrossRef

  96. 96
    Alexander R. Moschen, Clemens Molnar, Anna Maria Wolf, Helmut Weiss, Ivo Graziadei, Susanne Kaser, Christoph F. Ebenbichler, Sylvia Stadlmann, Patrizia L. Moser, Herbert Tilg, Effects of weight loss induced by bariatric surgery on hepatic adipocytokine expression, Journal of Hepatology, 2009, 51, 4, 765

    CrossRef

  97. 97
    Brent A. Neuschwander-Tetri, Lifestyle Modification as the Primary Treatment of NASH, Clinics in Liver Disease, 2009, 13, 4, 649

    CrossRef

  98. 98
    Abby B. Siegel, Andrew X. Zhu, Metabolic syndrome and hepatocellular carcinoma, Cancer, 2009, 115, 24
  99. 99
    Anjana A. Pillai, Mary E. Rinella, Non-Alcoholic Fatty Liver Disease: Is Bariatric Surgery the Answer?, Clinics in Liver Disease, 2009, 13, 4, 689

    CrossRef

  100. 100
    Kenneth Cusi, Nonalcoholic fatty liver disease in type 2 diabetes mellitus, Current Opinion in Endocrinology, Diabetes and Obesity, 2009, 16, 2, 141

    CrossRef

  101. 101
    Teoman Dogru, Cemal Nuri Ercin, Ilker Tasci, Serkan Tapan, Zeki Yesilova, Ahmet Uygun, Orlistat for overweight subjects with nonalcoholic steatohepatitis, Hepatology, 2009, 49, 6
  102. 102
    Joanna K. Dowman, Deborah Stocken, Jeremy W. Tomlinson, Philip Newsome, Orlistat for overweight subjects with nonalcoholic steatohepatitis, Hepatology, 2009, 50, 1
  103. 103
    OWMNews, Obesity and Weight Management, 2009, 5, 4, 145

    CrossRef

  104. 104
    Vlad Ratziu, Shira Zelber-Sagi, Pharmacologic Therapy of Non-Alcoholic Steatohepatitis, Clinics in Liver Disease, 2009, 13, 4, 667

    CrossRef

  105. 105
    Onpan Cheung, Arun J Sanyal, Recent advances in nonalcoholic fatty liver disease, Current Opinion in Gastroenterology, 2009, 25, 3, 230

    CrossRef

  106. 106
    Stephen Harrison, Elizabeth Brunt, Brent Neuschwander-Tetri, Reply:, Hepatology, 2009, 50, 1
  107. 107
    V. Ratziu, T. Poynard, Stéatohépatite métabolique : 30 ans de recherches qui ont changé la NASH, Gastroentérologie Clinique et Biologique, 2009, 33, 8-9, 850

    CrossRef

  108. 108
    A. Pariente, Stéatopathie métabolique : prise en charge, Gastroentérologie Clinique et Biologique, 2009, 33, 5, 413

    CrossRef

  109. 109
    Stephen H. Caldwell, Curtis K. Argo, Non-Alcoholic Fatty Liver Disease and Nutrition,
  110. 110
    Arthur J. McCullough, Srinivasan Dasarathy, Nonalcoholic fatty liver disease,
  111. 111
    Stephen H. Caldwell, Curtis K. Argo, Abdullah M. S. Al-Osaimi, Nonalcoholic Fatty Liver Disease,
  112. 112
    E. Jenny Heathcote, Eve A. Roberts, Obesity and its Hepatic Complications in Adults and Children,
  113. 113
    Lijun Peng, Jiyao Wang, Feng Li, Weight reduction for non-alcoholic fatty liver disease, The Cochrane Library,
  114. 114
    Lijun Peng, Jiyao Wang, Feng Li, Weight reduction for non-alcoholic fatty liver disease, The Cochrane Library,